About athenahealth (NASDAQ:ATHN)
athenahealth, Inc., together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services. The company also provides athenahealth Population Health, a cloud-based population health service; and Epocrates services that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, and market research. In addition, it offers athenahealth Health Plan data exchange facilitates to exchange the data between providers and health plans for the healthcare operations of clients; athenaOne Analytics that includes an analytics and dashboard application, as well as provides visibility into the financial and operational health of an organization; and pre-certification processing and referral processing services. The company serves healthcare providers, medical groups, and health systems through its direct sales force and channel partners in the United States and internationally. athenahealth, Inc. was formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. The company was founded in 1997 and is headquartered in Watertown, Massachusetts.
Industry, Sector and Symbol
Industry Business services, not elsewhere classified
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:ATHN
CUSIP04685W10
Phone617-402-1000
Debt
Debt-to-Equity Ratio0.32%
Current Ratio1.84%
Quick Ratio1.84%
Price-To-Earnings
Trailing P/E Ratio90.99
Forward P/E Ratio53.16
P/E Growth3.04
Sales & Book Value
Annual Sales$1.22 billion
Price / Sales4.73
Cash Flow$5.2067 per share
Price / Cash27.67
Book Value$19.78 per share
Price / Book7.28
Profitability
EPS (Most Recent Fiscal Year)$1.57
Net Income$53.10 million
Net Margins4.35%
Return on Equity9.21%
Return on Assets5.35%
Miscellaneous
Employees5,156
Outstanding Shares40,100,000
athenahealth (NASDAQ:ATHN) Frequently Asked Questions
What is athenahealth's stock symbol?
athenahealth trades on the NASDAQ under the ticker symbol "ATHN."
How were athenahealth's earnings last quarter?
athenahealth (NASDAQ:ATHN) released its earnings results on Thursday, February, 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.63 by $0.48. The health services provider had revenue of $329.20 million for the quarter, compared to the consensus estimate of $319.64 million. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. The company's revenue was up 14.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.62 EPS. View athenahealth's Earnings History.
When is athenahealth's next earnings date?
What price target have analysts set for ATHN?
25 brokers have issued twelve-month price objectives for athenahealth's shares. Their forecasts range from $88.00 to $186.00. On average, they expect athenahealth's share price to reach $145.3478 in the next twelve months. View Analyst Ratings for athenahealth.
What are Wall Street analysts saying about athenahealth stock?
Here are some recent quotes from research analysts about athenahealth stock:
- 1. Canaccord Genuity analysts commented, "We remain neutral on the stock until we get a better understanding of the restructuring initiatives, financial predictability, and the go-forward growth strategy. Pre-call takeaways: Upside to revenue, with significant bottom-line beat. Rev. of $329.2M (+14.2%) beat our est. $324.8M and cons. $320.0M, and came in at the high end of implied guidance range $309-$329M. Beats on adjusted gross margin and all expense line items enabled the company to post non-GAAP op. inc. of $77.6M (+82.6%), far surpassing us and cons. both near ~$45M and implied guidance of $38-53M. Adj-EPS of $1.11 also beat our est. $0.65 and cons. $0.63." (2/1/2018)
- 2. Cantor Fitzgerald analysts commented, "This morning, athenaHealth filed an 8-K indicating that it implemented a change in control severance plan for certain executives." (10/27/2017)
Who are some of athenahealth's key competitors?
Some companies that are related to athenahealth include Ctrip (CTRP), Fleetcor (FLT), Global Payments (GPN), TSYS (TSS), Cielo (CIOXY), Worldpay (WP), MercadoLibre (MELI), First Data (FDC), CoStar Group (CSGP), MSCI (MSCI), Broadridge Financial Solutions (BR), Akamai Technologies (AKAM), Nielsen (NLSN), Alliance Data (ADS) and Zillow (Z).
Who are athenahealth's key executives?
athenahealth's management team includes the folowing people:
- Mr. Jonathan J. Bush, Pres, CEO & Director (Age 49)
- Mr. Timothy John O'Brien, Sr. VP of Commercial Operations & Chief Marketing Officer (Age 42)
- Dr. Stephen N. Kahane M.D., M.S, Exec. Director of Client Organization (Age 60)
- Mr. John A. Kane, Director (Age 65)
- Mr. Marc A. Levine, Exec. VP, CFO, Treasurer & Principal Accounting Officer (Age 58)
Has athenahealth been receiving favorable news coverage?
Media headlines about ATHN stock have trended positive recently, Accern Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. athenahealth earned a media sentiment score of 0.25 on Accern's scale. They also gave news coverage about the health services provider an impact score of 46.46 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of athenahealth?
Shares of ATHN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is athenahealth's stock price today?
One share of ATHN stock can currently be purchased for approximately $144.09.
How big of a company is athenahealth?
athenahealth has a market capitalization of $5.86 billion and generates $1.22 billion in revenue each year. The health services provider earns $53.10 million in net income (profit) each year or $1.57 on an earnings per share basis. athenahealth employs 5,156 workers across the globe.
How can I contact athenahealth?
athenahealth's mailing address is 311 ARSENAL STREET, WATERTOWN MA, 02472. The health services provider can be reached via phone at 617-402-1000 or via email at [email protected]
MarketBeat Community Rating for athenahealth (ATHN)
MarketBeat's community ratings are surveys of what our community members think about athenahealth and other stocks. Vote "Outperform" if you believe ATHN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATHN will underperform the S&P 500 over the long term. You may vote once every thirty days.
athenahealth (NASDAQ:ATHN) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
25 Wall Street analysts have issued ratings and price targets for athenahealth in the last 12 months. Their average twelve-month price target is $145.3478, suggesting that the stock has a possible upside of 0.89%. The high price target for ATHN is $186.00 and the low price target for ATHN is $88.00. There are currently 1 sell rating, 17 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.24 | 2.24 | 2.28 | 2.40 |
| Ratings Breakdown: | 1 Sell Rating(s)
17 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
17 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
16 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
13 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $145.3478 | $144.3478 | $142.9565 | $144.3043 |
| Price Target Upside: | 0.89% upside | 2.14% upside | 13.88% upside | 14.16% upside |
athenahealth (NASDAQ:ATHN) Consensus Price Target History
athenahealth (NASDAQ:ATHN) Analyst Ratings History
Show:
(Data available from 4/24/2016 forward)
athenahealth (NASDAQ:ATHN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
athenahealth (NASDAQ ATHN) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.20%
athenahealth (NASDAQ ATHN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/2/2018 | Jonathan Bush | CEO | Sell | 5,000 | $140.47 | $702,350.00 | 340,106 |  |
| 3/26/2018 | Jonathan D. Porter | SVP | Sell | 150 | $141.00 | $21,150.00 | | |
| 3/2/2018 | Bradford Kyle Armbrester | SVP | Sell | 2,235 | $138.70 | $309,994.50 | 10,146 | |
| 3/2/2018 | Timothy John O'brien | CMO | Sell | 3,064 | $137.27 | $420,595.28 | 11,320 | |
| 3/1/2018 | Daniel P Haley | Insider | Sell | 1,153 | $136.83 | $157,764.99 | 12,436 | |
| 3/1/2018 | Jonathan Bush | CEO | Sell | 250 | $139.27 | $34,817.50 | 321,533 | |
| 2/27/2018 | Jeffrey R. Immelt | Director | Buy | 3,600 | $141.04 | $507,744.00 | | |
| 2/27/2018 | Jonathan Bush | CEO | Sell | 4,750 | $141.11 | $670,272.50 | 320,557 | |
| 2/26/2018 | Jonathan D. Porter | SVP | Sell | 150 | $139.87 | $20,980.50 | | |
| 2/20/2018 | Jeffrey R Immelt | Director | Buy | 7,200 | $138.44 | $996,768.00 | 678 | |
| 2/5/2018 | Jonathan Bush | CEO | Sell | 25,000 | $145.00 | $3,625,000.00 | | |
| 2/2/2018 | Brandon H Hull | Director | Sell | 653 | $133.00 | $86,849.00 | 5,230 | |
| 2/1/2018 | Jonathan Bush | CEO | Sell | 5,000 | $122.69 | $613,450.00 | 320,807 | |
| 1/26/2018 | Jonathan D. Porter | SVP | Sell | 150 | $128.26 | $19,239.00 | | |
| 1/2/2018 | David Eric Robinson | Director | Sell | 5,000 | $133.94 | $669,700.00 | 8,596 | |
| 12/29/2017 | Jonathan D Porter | SVP | Sell | 150 | $134.52 | $20,178.00 | | |
| 12/29/2017 | Jonathan D. Porter | SVP | Sell | 150 | $134.52 | $20,178.00 | | |
| 12/26/2017 | Amy Abernethy | Director | Sell | 500 | $134.18 | $67,090.00 | 4,045 | |
| 12/26/2017 | Amy Abernethy | Director | Sell | 500 | $134.18 | $67,090.00 | 4,045 | |
| 12/26/2017 | Jonathan Bush | CEO | Sell | 30,000 | $134.80 | $4,044,000.00 | 320,807 | |
| 12/26/2017 | Jonathan Bush | CEO | Sell | 30,000 | $134.80 | $4,044,000.00 | 320,807 | |
| 12/1/2017 | Brandon H. Hull | Director | Sell | 800 | $132.97 | $106,376.00 | | |
| 11/20/2017 | Brandon H. Hull | Director | Sell | 800 | $130.00 | $104,000.00 | | |
| 10/27/2017 | Bradford Kyle Armbrester | SVP | Sell | 1,000 | $128.56 | $128,560.00 | | |
| 10/20/2017 | Brandon H. Hull | Director | Sell | 800 | $130.00 | $104,000.00 | | |
| 10/2/2017 | Daniel P Haley | Insider | Sell | 1,583 | $124.56 | $197,178.48 | 13,408 | |
| 10/2/2017 | Jonathan Bush | CEO | Sell | 4,000 | $124.17 | $496,680.00 | 319,807 | |
| 9/15/2017 | Jonathan D. Porter | SVP | Sell | 300 | $130.38 | $39,114.00 | | |
| 9/1/2017 | Brandon H. Hull | Director | Sell | 800 | $140.95 | $112,760.00 | | |
| 9/1/2017 | Jonathan Bush | CEO | Sell | 4,000 | $139.77 | $559,080.00 | 319,807 | |
| 8/15/2017 | Jonathan D. Porter | SVP | Sell | 300 | $142.88 | $42,864.00 | | |
| 8/1/2017 | Brandon H. Hull | Director | Sell | 800 | $140.01 | $112,008.00 | | |
| 8/1/2017 | Jonathan Bush | CEO | Sell | 4,000 | $143.31 | $573,240.00 | 319,807 | |
| 7/21/2017 | Jonathan D. Porter | SVP | Sell | 422 | $154.00 | $64,988.00 | | |
| 7/17/2017 | Jonathan D. Porter | SVP | Sell | 300 | $143.13 | $42,939.00 | | |
| 7/3/2017 | Brandon H. Hull | Director | Sell | 800 | $140.81 | $112,648.00 | | |
| 7/3/2017 | Jonathan Bush | CEO | Sell | 4,000 | $140.52 | $562,080.00 | 319,807 | |
| 6/15/2017 | Jonathan D. Porter | SVP | Sell | 300 | $142.27 | $42,681.00 | | |
| 6/5/2017 | Karl Stubelis | CFO | Sell | 3,952 | $138.98 | $549,248.96 | 21,810 | |
| 5/18/2017 | Bradford Kyle Armbrester | SVP | Sell | 2,431 | $130.00 | $316,030.00 | | |
| 5/18/2017 | Brandon H. Hull | Director | Sell | 1,600 | $130.00 | $208,000.00 | | |
| 5/18/2017 | Jonathan Bush | CEO | Sell | 4,000 | $125.85 | $503,400.00 | 319,807 | |
| 5/15/2017 | Jonathan D. Porter | SVP | Sell | 300 | $109.48 | $32,844.00 | | |
| 4/25/2017 | Jonathan Bush | CEO | Sell | 8,000 | $120.00 | $960,000.00 | 319,807 | |
| 1/27/2017 | John A Kane | Director | Sell | 2,875 | $123.11 | $353,941.25 | 8,958 | |
| 1/12/2017 | Jonathan Bush | CEO | Sell | 4,000 | $120.00 | $480,000.00 | 312,109 | |
| 12/15/2016 | Amy Abernethy | Director | Sell | 1,000 | $117.15 | $117,150.00 | 2,649 | |
| 12/15/2016 | Ed Park | COO | Sell | 2,500 | $117.15 | $292,875.00 | 13,219 | |
| 12/15/2016 | Jonathan Bush | CEO | Sell | 8,000 | $120.00 | $960,000.00 | 312,109 | |
| 12/1/2016 | Ed Park | COO | Sell | 1,500 | $94.60 | $141,900.00 | 10,719 | |
| 10/27/2016 | John A. Kane | Director | Sell | 5,750 | $122.63 | $705,122.50 | | |
| 10/10/2016 | Bradford Kyle Armbrester | SVP | Sell | 2,545 | $130.00 | $330,850.00 | | |
| 10/10/2016 | Brandon H Hull | Director | Sell | 2,400 | $130.00 | $312,000.00 | 3,987 | |
| 10/3/2016 | Daniel P Haley | SVP | Sell | 2,109 | $124.43 | $262,422.87 | 3,195 | |
| 10/3/2016 | Jonathan Bush | CEO | Sell | 4,000 | $124.34 | $497,360.00 | 312,109 | |
| 9/7/2016 | Karl Stubelis | VP | Sell | 928 | $123.36 | $114,478.08 | 1,375 | |
| 8/15/2016 | Ed Park | COO | Sell | 4,000 | $124.20 | $496,800.00 | 20,719 | |
| 8/1/2016 | Jonathan Bush | CEO | Sell | 4,000 | $128.19 | $512,760.00 | 312,109 | |
| 7/27/2016 | John A Kane | Director | Sell | 2,875 | $128.81 | $370,328.75 | 10,708 | |
| 7/6/2016 | Ed Park | COO | Sell | 1,500 | $136.85 | $205,275.00 | 18,819 | |
| 7/1/2016 | Brandon H Hull | Director | Sell | 800 | $137.48 | $109,984.00 | 6,387 | |
| 7/1/2016 | Jonathan Bush | CEO | Sell | 4,000 | $138.21 | $552,840.00 | 312,109 | |
| 6/2/2016 | Brandon H Hull | Director | Sell | 800 | $130.00 | $104,000.00 | 7,187 | |
| 6/1/2016 | Ed Park | COO | Sell | 1,500 | $125.82 | $188,730.00 | 19,819 | |
| 6/1/2016 | Jonathan Bush | CEO | Sell | 4,000 | $125.97 | $503,880.00 | 312,109 | |
| 5/4/2016 | Ed Park | COO | Sell | 1,500 | $127.81 | $191,715.00 | 21,819 | |
| 5/2/2016 | Brandon H Hull | Director | Sell | 800 | $132.74 | $106,192.00 | 7,987 | |
| 5/2/2016 | Jonathan Bush | CEO | Sell | 4,000 | $132.09 | $528,360.00 | 312,109 | |
| 5/2/2016 | Kristi Ann Matus | EVP | Sell | 415 | $133.27 | $55,307.05 | 34,116 | |
| 4/25/2016 | Karl Stubelis | VP | Sell | 547 | $138.64 | $75,836.08 | | |
| 4/6/2016 | Ed Park | COO | Sell | 1,500 | $139.15 | $208,725.00 | 22,919 | |
| 4/1/2016 | Brandon H Hull | Director | Sell | 800 | $137.72 | $110,176.00 | 8,787 | |
| 4/1/2016 | Jonathan Bush | CEO | Sell | 4,000 | $138.44 | $553,760.00 | 307,408 | |
| 4/1/2016 | Kristi Ann Matus | EVP | Sell | 415 | $138.61 | $57,523.15 | 34,531 | |
| 3/3/2016 | Bradford Kyle Armbrester | SVP | Sell | 1,369 | $132.04 | $180,762.76 | | |
| 3/1/2016 | Brandon H Hull | Director | Sell | 1,600 | $130.00 | $208,000.00 | 8,687 | |
| 3/1/2016 | Daniel P Haley | SVP | Sell | 1,279 | $130.64 | $167,088.56 | 365 | |
| 3/1/2016 | Ed Park | COO | Sell | 1,500 | $131.66 | $197,490.00 | 26,270 | |
| 3/1/2016 | Jonathan Bush | CEO | Sell | 4,000 | $129.61 | $518,440.00 | 312,109 | |
| 3/1/2016 | Kristi Ann Matus | EVP | Sell | 415 | $129.53 | $53,754.95 | 33,357 | |
| 3/1/2016 | Timothy John O'brien | CMO | Sell | 846 | $132.25 | $111,883.50 | 62 | |
| 2/16/2016 | Bradford Kyle Armbrester | SVP | Sell | 1,657 | $127.11 | $210,621.27 | 2,500 | |
| 2/16/2016 | Timothy John O'brien | CMO | Sell | 816 | $127.08 | $103,697.28 | 1,250 | |
| 2/3/2016 | Ed Park | COO | Sell | 1,500 | $140.61 | $210,915.00 | 27,433 | |
| 2/1/2016 | Jonathan Bush | CEO | Sell | 4,000 | $140.14 | $560,560.00 | 308,109 | |
| 2/1/2016 | Kristi Ann Matus | EVP | Sell | 415 | $141.08 | $58,548.20 | 33,772 | |
| 1/27/2016 | John A. Kane | Director | Sell | 2,875 | $140.81 | $404,828.75 | 6,133 | |
| 1/6/2016 | Ed Park | COO | Sell | 1,500 | $161.89 | $242,835.00 | 28,933 | |
| 1/4/2016 | Jonathan Bush | CEO | Sell | 4,000 | $156.79 | $627,160.00 | 308,109 | |
| 1/4/2016 | Kristi Ann Matus | EVP | Sell | 415 | $159.06 | $66,009.90 | 34,187 | |
| 12/2/2015 | Ed Park | COO | Sell | 1,500 | $166.81 | $250,215.00 | 30,433 | |
| 11/20/2015 | Stephen N Kahane | EVP | Sell | 1,280 | $157.80 | $201,984.00 | 17,829 | |
| 11/6/2015 | Stephen N Kahane | EVP | Sell | 5,000 | $159.51 | $797,550.00 | 19,109 | |
| 11/4/2015 | Ed Park | COO | Sell | 1,500 | $162.32 | $243,480.00 | 31,933 | |
| 11/3/2015 | Jonathan Bush | CEO | Sell | 14,750 | $156.50 | $2,308,375.00 | 311,234 | |
| 10/27/2015 | John A. Kane | Director | Sell | 2,875 | $150.44 | $432,515.00 | 6,133 | |
| 10/23/2015 | Jonathan Bush | CEO | Sell | 20,000 | $157.50 | $3,150,000.00 | 311,234 | |
| 10/23/2015 | Robert Cosinuke | CMO | Sell | 1,211 | $159.02 | $192,573.22 | 40,322 | |
| 10/23/2015 | Stephen N Kahane | EVP | Sell | 5,000 | $150.50 | $752,500.00 | 24,109 | |
| 10/20/2015 | Stephen N Kahane | EVP | Sell | 2,000 | $132.88 | $265,760.00 | 29,109 | |
| 10/7/2015 | Ed Park | COO | Sell | 1,500 | $134.23 | $201,345.00 | 33,433 | |
| 10/2/2015 | Jonathan Bush | CEO | Sell | 1,000 | $130.74 | $130,740.00 | 311,234 | |
| 9/15/2015 | Stephen N Kahane | EVP | Sell | 2,000 | $135.77 | $271,540.00 | 31,031 | |
| 9/2/2015 | Ed Park | COO | Sell | 1,500 | $129.64 | $194,460.00 | 34,933 | |
| 9/2/2015 | Jonathan Bush | CEO | Sell | 1,000 | $131.09 | $131,090.00 | 311,234 | |
| 8/18/2015 | Stephen N Kahane | EVP | Sell | 2,000 | $141.49 | $282,980.00 | | |
| 7/24/2015 | David Eric Robinson | Director | Sell | 10,000 | $130.00 | $1,300,000.00 | | |
| 7/21/2015 | Stephen N Kahane | EVP | Sell | 2,000 | $117.32 | $234,640.00 | | |
| 7/2/2015 | Jonathan Bush | CEO | Sell | 1,000 | $114.17 | $114,170.00 | | |
| 6/2/2015 | Jonathan Bush | CEO | Sell | 1,000 | $115.32 | $115,320.00 | | |
| 4/27/2015 | John A Kane | Director | Sell | 2,875 | $125.35 | $360,381.25 | | |
| 4/14/2015 | Karl Stubelis | VP | Sell | 1,115 | $126.28 | $140,802.20 | | |
| 4/2/2015 | Jonathan Bush | CEO | Sell | 1,000 | $118.77 | $118,770.00 | | |
| 3/10/2015 | James L Mann | Director | Sell | 13,106 | $121.27 | $1,589,364.62 | | |
| 3/3/2015 | Robert Cosinuke | CMO | Sell | 6,000 | $128.15 | $768,900.00 | | |
| 2/24/2015 | Jonathan Bush | CEO | Sell | 2,499 | $130.23 | $325,444.77 | | |
| 2/18/2015 | Jonathan Bush | CEO | Sell | 2,498 | $132.04 | $329,835.92 | | |
| 2/10/2015 | Jonathan Bush | CEO | Sell | 7,495 | $135.82 | $1,017,970.90 | | |
| 2/5/2015 | David Eric Robinson | Director | Sell | 25,000 | $143.17 | $3,579,250.00 | | |
| 2/3/2015 | Robert Cosinuke | CMO | Sell | 6,000 | $139.06 | $834,360.00 | | |
| 1/5/2015 | David Eric Robinson | Director | Sell | 25,000 | $145.14 | $3,628,500.00 | | |
| 1/5/2015 | Robert Cosinuke | CMO | Sell | 6,000 | $145.18 | $871,080.00 | | |
| 12/22/2014 | Robert Cosinuke | CMO | Sell | 6,000 | $139.32 | $835,920.00 | | |
| 12/2/2014 | Jonathan Bush | CEO | Sell | 1,000 | $116.55 | $116,550.00 | | |
| 10/10/2014 | Robert Cosinuke | CMO | Sell | 3,000 | $123.78 | $371,340.00 | | |
| 10/2/2014 | Jonathan Bush | CEO | Sell | 1,000 | $128.41 | $128,410.00 | | |
| 9/10/2014 | Robert Cosinuke | CMO | Sell | 6,000 | $138.08 | $828,480.00 | | |
| 8/11/2014 | Robert Cosinuke | CMO | Sell | 6,000 | $129.43 | $776,580.00 | | |
| 8/4/2014 | Jonathan Bush | CEO | Sell | 1,000 | $121.58 | $121,580.00 | | |
| 7/10/2014 | Robert Cosinuke | CMO | Sell | 6,000 | $120.10 | $720,600.00 | | |
| 7/2/2014 | Jonathan Bush | CEO | Sell | 1,000 | $129.45 | $129,450.00 | | |
| 7/1/2014 | Stephen N Kahane | Insider | Sell | 5,000 | $127.60 | $638,000.00 | | |
| 6/12/2014 | David Eric Robinson | Director | Sell | 30,000 | $124.12 | $3,723,600.00 | | |
| 6/10/2014 | Robert Cosinuke | CMO | Sell | 6,000 | $125.07 | $750,420.00 | | |
| 6/2/2014 | Jonathan Bush | CEO | Sell | 1,000 | $125.82 | $125,820.00 | | |
| 6/2/2014 | Stephen N Kahane | Insider | Sell | 5,000 | $126.42 | $632,100.00 | | |
| 5/2/2014 | Jonathan Bush | CEO | Sell | 1,000 | $123.21 | $123,210.00 | 311,234 | |
| 5/1/2014 | Stephen Kahane | Insider | Sell | 5,000 | $121.96 | $609,800.00 | 64,285 | |
| 4/16/2014 | Stephen Kahane | Insider | Sell | 10,000 | $143.96 | $1,439,600.00 | 69,285 | |
| 4/14/2014 | David Eric Robinson | Director | Sell | 60,000 | $140.61 | $8,436,600.00 | 3,692 | |
| 4/10/2014 | Robert Cosinuke | CMO | Sell | 6,000 | $151.14 | $906,840.00 | 44,804 | |
| 4/2/2014 | Jonathan Bush | CEO | Sell | 1,000 | $161.74 | $161,740.00 | 311,234 | |
| 3/10/2014 | Robert Cosinuke | CMO | Sell | 6,000 | $181.60 | $1,089,600.00 | 46,277 | |
| 2/18/2014 | Timothy Adams | CFO | Sell | 30,000 | $194.58 | $5,837,400.00 | 40,327 | |
| 2/12/2014 | Dev Ittycheria | Director | Sell | 2,000 | $181.17 | $362,340.00 | 8,574 | |
| 2/10/2014 | Robert Cosinuke | CMO | Sell | 6,000 | $172.72 | $1,036,320.00 | 53,321 | |
| 2/3/2014 | Daniel Orenstein | SVP | Sell | 1,000 | $146.73 | $146,730.00 | 31,262 | |
| 2/3/2014 | David Eric Robinson | Director | Sell | 4,000 | $146.86 | $587,440.00 | 2,058 | |
| 1/10/2014 | Robert Cosinuke | CMO | Sell | 6,000 | $132.92 | $797,520.00 | 53,321 | |
| 1/3/2014 | David Eric Robinson | Director | Sell | 4,000 | $131.86 | $527,440.00 | 2,058 | |
| 12/10/2013 | Robert Cosinuke | CMO | Sell | 6,000 | $132.77 | $796,620.00 | 53,321 | |
| 12/3/2013 | David Eric Robinson | Director | Sell | 4,000 | $132.48 | $529,920.00 | 2,058 | |
| 12/2/2013 | Jonathan Bush | CEO | Sell | 1,000 | $132.24 | $132,240.00 | 311,759 | |
| 11/4/2013 | David Eric Robinson | Director | Sell | 4,000 | $137.26 | $549,040.00 | | |
| 11/4/2013 | Jonathan Bush | CEO | Sell | 1,000 | $137.26 | $137,260.00 | | |
| 11/1/2013 | Daniel H Orenstein | SVP | Sell | 1,000 | $133.15 | $133,150.00 | | |
| 10/21/2013 | Timothy M Adams | CFO | Sell | 20,000 | $138.39 | $2,767,800.00 | | |
| 10/18/2013 | Ed Park | COO | Sell | 10,021 | $123.36 | $1,236,190.56 | | |
| 10/18/2013 | Jonathan Bush | CEO | Sell | 20,000 | $120.00 | $2,400,000.00 | | |
| 10/10/2013 | Robert Cosinuke | CMO | Sell | 6,000 | $108.21 | $649,260.00 | 53,321 | |
| 10/3/2013 | David Eric Robinson | Director | Sell | 4,000 | $111.01 | $444,040.00 | | |
| 10/2/2013 | Jonathan Bush | CEO | Sell | 1,000 | $110.16 | $110,160.00 | | |
| 9/10/2013 | Robert Cosinuke | CMO | Sell | 6,000 | $109.68 | $658,080.00 | | |
| 9/3/2013 | Daniel Orenstein | SVP | Sell | 1,000 | $106.73 | $106,730.00 | 31,262 | |
| 9/3/2013 | David Eric Robinson | Director | Sell | 4,000 | $106.53 | $426,120.00 | 2,058 | |
| 9/3/2013 | Jonathan Bush | CEO | Sell | 22,105 | $106.45 | $2,353,077.25 | 302,231 | |
| 8/19/2013 | John Kane | Director | Sell | 2,000 | $111.23 | $222,460.00 | 5,052 | |
| 8/15/2013 | John Kane | Director | Sell | 5,000 | $110.03 | $550,150.00 | 5,052 | |
| 8/12/2013 | Robert Cosinuke | CMO | Sell | 6,000 | $115.72 | $694,320.00 | 53,321 | |
| 8/5/2013 | David Eric Robinson | Director | Sell | 4,000 | $114.01 | $456,040.00 | | |
| 8/1/2013 | Daniel H Orenstein | SVP | Sell | 1,000 | $113.73 | $113,730.00 | | |
| 8/1/2013 | Jonathan Bush | CEO | Sell | 5,000 | $113.94 | $569,700.00 | 302,231 | |
| 7/12/2013 | Timothy M Adams | CFO | Sell | 10,000 | $106.14 | $1,061,400.00 | | |
| 7/11/2013 | David Eric Robinson | Director | Sell | 4,000 | $90.00 | $360,000.00 | | |
| 7/10/2013 | Robert Cosinuke | CMO | Sell | 6,000 | $87.06 | $522,360.00 | | |
| 7/1/2013 | Daniel H Orenstein | SVP | Sell | 1,000 | $85.01 | $85,010.00 | | |
| 7/1/2013 | Jonathan Bush | CEO | Sell | 5,000 | $85.39 | $426,950.00 | | |
| 6/17/2013 | David Eric Robinson | Director | Sell | 4,000 | $90.00 | $360,000.00 | | |
| 6/10/2013 | Robert Cosinuke | CMO | Sell | 6,000 | $85.74 | $514,440.00 | | |
| 6/3/2013 | Daniel H Orenstein | SVP | Sell | 1,000 | $84.22 | $84,220.00 | | |
| 6/3/2013 | Jonathan Bush | CEO | Sell | 5,000 | $84.39 | $421,950.00 | | |
| 5/10/2013 | Robert Cosinuke | CMO | Sell | 6,000 | $84.80 | $508,800.00 | | |
| 5/1/2013 | Jonathan Bush | CEO | Sell | 5,000 | $95.70 | $478,500.00 | | |
| 2/26/2013 | David Eric Robinson | Director | Sell | 10,000 | $90.13 | $901,300.00 | | |
| 8/10/2012 | Robert Cosinuke | CMO | Sell | 3,000 | $92.35 | $277,050.00 | | |
(Data available from 1/1/2013 forward)
athenahealth (NASDAQ ATHN) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | athenahealth (ATHN) Coverage Initiated at JPMorgan Chase
www.americanbankingnews.com - April 24 at 8:28 AM |
 | Form 8-K ATHENAHEALTH INC For: Apr 17
www.streetinsider.com - April 24 at 8:08 AM |
| JPMorgan Assumes athenahealth (ATHN) at Neutral
www.streetinsider.com - April 24 at 8:08 AM |
 | Champlain College Online Forms truED Alliance Partnership with athenahealth
www.businesswire.com - April 24 at 8:08 AM |
 | 3 Things You Should Know About Today's Top Entrepreneurs
www.fool.com - April 22 at 6:42 PM |
| athenahealth (ATHN) Cut to "Hold" at BidaskClub
www.americanbankingnews.com - April 19 at 11:52 PM |
| athenahealth (ATHN) Rating Lowered to Sell at BidaskClub
www.americanbankingnews.com - April 19 at 11:03 AM |
 | Can Business Services Aid athenahealth's (ATHN) Q1 Earnings?
www.zacks.com - April 19 at 8:04 AM |
| athenahealth (ATHN) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - April 18 at 2:48 AM |
| athenahealth (ATHN) Rating Reiterated by SunTrust Banks
www.americanbankingnews.com - April 17 at 10:21 PM |
 | Simple Interact Partners with athenahealth's 'More Disruption Please' Program
www.benzinga.com - April 17 at 6:08 PM |
| athenahealth (ATHN) Downgraded by First Analysis
www.americanbankingnews.com - April 16 at 10:54 PM |
| athenahealth (ATHN) Lifted to "Hold" at ValuEngine
www.americanbankingnews.com - April 16 at 7:35 PM |
 | Should You Buy athenahealth Inc (NASDAQ:ATHN) When Insiders Do?
finance.yahoo.com - April 16 at 5:38 PM |
| athenahealth (ATHN) Downgraded by Cowen
www.americanbankingnews.com - April 15 at 9:43 AM |
| athenahealth (ATHN) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 14 at 6:23 PM |
| athenahealth, Inc (ATHN) Expected to Post Quarterly Sales of $318.72 Million
www.americanbankingnews.com - April 13 at 4:31 AM |
| Edited Transcript of ATHN presentation 8-Mar-17 2:15pm GMT
finance.yahoo.com - April 12 at 5:54 PM |
| $0.74 Earnings Per Share Expected for athenahealth, Inc (ATHN) This Quarter
www.americanbankingnews.com - April 11 at 8:23 AM |
| athenahealth (ATHN) Rating Increased to Equal Weight at First Analysis
www.americanbankingnews.com - April 6 at 11:31 AM |
 | Jellyfish Health Partners with athenahealth's 'More Disruption Please' Program to Deliver the Ultimate Patient Experience
www.prnewswire.com - April 5 at 5:28 PM |
| athenahealth's (ATHN) Buy Rating Reiterated at SunTrust Banks
www.americanbankingnews.com - April 5 at 2:17 PM |
| Form 4 ATHENAHEALTH INC For: Apr 02 Filed by: Bush Jonathan
www.streetinsider.com - April 5 at 9:51 AM |
| athenahealth, Inc (ATHN) CEO Sells $702,350.00 in Stock
www.americanbankingnews.com - April 4 at 10:38 PM |
| Einhorn Isn’t Mystified Nor Befuddled By Greenlight Capital’s Large Losses
finance.yahoo.com - April 4 at 4:25 PM |
| Commentary: Why We Need to Give Doctors Time to Listen
finance.yahoo.com - April 3 at 8:07 AM |
| athenahealth Announces First Quarter 2018 Earnings Conference Call
finance.yahoo.com - April 2 at 5:38 PM |
| athenahealth, Inc (ATHN) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - April 1 at 11:38 AM |
| athenahealth (ATHN) Downgraded to "Sell" at BidaskClub
www.americanbankingnews.com - March 28 at 12:34 AM |
| athenahealth, Inc (ATHN) SVP Sells $21,150.00 in Stock
www.americanbankingnews.com - March 27 at 11:14 PM |
| $318.72 Million in Sales Expected for athenahealth, Inc (ATHN) This Quarter
www.americanbankingnews.com - March 27 at 5:56 AM |
| athenahealth (ATHN) Downgraded by ValuEngine to "Sell"
www.americanbankingnews.com - March 25 at 8:45 PM |
| Zacks: Brokerages Expect athenahealth, Inc (ATHN) to Post $0.74 EPS
www.americanbankingnews.com - March 25 at 8:48 AM |
| athenahealth (ATHN) Coverage Initiated at Bank of America
www.americanbankingnews.com - March 24 at 9:28 PM |
 | Wright Medical (WMGI) Poised on Acquisitions Amid Forex Woes - Nasdaq
www.nasdaq.com - March 22 at 8:10 AM |
| Here's Why You Should Invest in Baxter International Now - Nasdaq
www.nasdaq.com - March 21 at 8:22 AM |
| DocSpera Partners with athenahealth's 'More Disruption Please' Program to Streamline Pre- and Post-Operative Coordination and Improve Decision Support
www.prnewswire.com - March 20 at 8:12 AM |
| What's Driving Orthofix International to a New 52-Week High - Nasdaq
www.nasdaq.com - March 20 at 8:10 AM |
| athenahealth, Inc (ATHN) Expected to Announce Quarterly Sales of $318.72 Million
www.americanbankingnews.com - March 10 at 11:23 AM |
| $0.73 EPS Expected for athenahealth, Inc (ATHN) This Quarter
www.americanbankingnews.com - March 8 at 1:08 AM |
| athenahealth, Inc (ATHN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - March 7 at 11:15 AM |
| 3 Reasons Why You Should Invest in athenahealth (ATHN) Stock - Nasdaq
www.nasdaq.com - March 7 at 8:04 AM |
| athenahealth, Inc (ATHN) Holdings Cut by Avalon Global Asset Management LLC
www.americanbankingnews.com - March 6 at 4:42 AM |
| Jonathan Bush Sells 250 Shares of athenahealth, Inc (ATHN) Stock
www.americanbankingnews.com - March 5 at 7:54 PM |
| athenahealth, Inc (ATHN) Insider Sells $157,764.99 in Stock
www.americanbankingnews.com - March 5 at 7:16 PM |
| Bradford Kyle Armbrester Sells 2,235 Shares of athenahealth, Inc (ATHN) Stock
www.americanbankingnews.com - March 5 at 7:00 PM |
| Insider Selling: athenahealth, Inc (ATHN) CMO Sells 3,064 Shares of Stock
www.americanbankingnews.com - March 5 at 6:40 PM |
| Gagnon Securities LLC Grows Position in athenahealth, Inc (ATHN)
www.americanbankingnews.com - March 3 at 5:10 PM |
 | athenahealth @ HIMSS18: Healthcare Providers, Care Staff, and Leadership Are Finally Being Freed from ... - GlobeNewswire (press release)
globenewswire.com - March 2 at 8:04 AM |
| athenahealth @ HIMSS18: Healthcare Providers, Care Staff, and Leadership Are Finally Being Freed from Administrative Burden
finance.yahoo.com - March 1 at 6:01 PM |
athenahealth (NASDAQ:ATHN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
athenahealth (NASDAQ:ATHN) Income Statement, Balance Sheet and Cash Flow Statement
athenahealth (NASDAQ ATHN) Stock Chart for Tuesday, April, 24, 2018
Loading chart…
